These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5868168)

  • 1. [Should the drug industry be nationalized? A debate on drugs].
    Fernström R
    Sven Farm Tidskr; 1965 Nov; 69(32):920-4. PubMed ID: 5868168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Private enterprise provides better and safer drugs].
    Monvall E
    Vardfacket; 1979 Mar; 3(6):17-8. PubMed ID: 258054
    [No Abstract]   [Full Text] [Related]  

  • 3. [The drug industry should be nationalized].
    Thomasson J
    Vardfacket; 1980 May; 4(9):18. PubMed ID: 6903072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Physicians' Union recommends centralization of information on drugs].
    Lakartidningen; 1968 May; 65(21):2162-4. PubMed ID: 5725028
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sweden a world leader when it comes to drugs and environment].
    Eckerman I
    Lakartidningen; 2010 Oct 20-26; 107(42):2586. PubMed ID: 21140536
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tendencies in drug research].
    Westerling R
    Sven Farm Tidskr; 1966 Apr; 70(12):293-6. PubMed ID: 5911655
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of drug safety].
    Liljestrand A
    Nord Med; 1967 Nov; 78(47):1535-9. PubMed ID: 6075272
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some aspects on drug safety control].
    Pekkarienen A
    Nord Med; 1967 Nov; 78(47):1539-42. PubMed ID: 6075273
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug adviser--a magician].
    Mollstedt B
    Lakartidningen; 1975 Mar; 72(12):1165, 1167. PubMed ID: 1134132
    [No Abstract]   [Full Text] [Related]  

  • 10. Medication during pregnancy and breast-feeding--a new Swedish system for classifying drugs.
    Sannerstedt R; Berglund F; Flodh H; Hedstrand AG
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):45-9. PubMed ID: 7372375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactions between the drug industry and the prescribers and their effects on the quality and quantity of drugs.
    Juma FD
    East Afr Med J; 1984 Nov; 61(11):793-6. PubMed ID: 6535700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the biotransformation of drugs and its significance in pharmaceutical industry].
    Hansen T
    Nord Med; 1967 Nov; 78(47):1549-54. PubMed ID: 6075279
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs, industry, and academia.
    Fitzgerald GA
    Science; 2008 Jun; 320(5883):1563. PubMed ID: 18566251
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased significance of adverse effects of drugs--a threat to the industry].
    Werkö L
    Lakartidningen; 2004 Dec; 101(50):4134-6. PubMed ID: 15631270
    [No Abstract]   [Full Text] [Related]  

  • 15. Funding pharmaceutical innovation through direct tax credits.
    Lybecker KM; Freeman RA
    Health Econ Policy Law; 2007 Jul; 2(Pt 3):267-84. PubMed ID: 18634650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality control of drugs and drug specialties].
    Meyrat A
    Pharm Acta Helv; 1967 Jan; 42(1):14-36. PubMed ID: 6043416
    [No Abstract]   [Full Text] [Related]  

  • 17. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A symposium on drugs and adverse effects. Serious problems--but the debate needs balance].
    Lennholm B
    Lakartidningen; 1996 Dec; 93(50):4653-4, 4657. PubMed ID: 8999263
    [No Abstract]   [Full Text] [Related]  

  • 19. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 20. Vendor competition, generic drugs spur drop in pharmaceutical prices.
    Seigner CA
    Mod Healthc; 1985 Oct; 15(21):56, 60-2. PubMed ID: 10317662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.